Clinical application of CyberKnife for high-risk central nervous system tumors: A clinical trial report of 60 cases

  • Authors:
    • Xin Wang
    • Yuan-Yuan Wang
    • Peng Jiang
    • Jian-Jun Ma
    • Zhen Qu
    • Han-Chen Liu
    • Shan-Shan Wang
    • Yi-Shan Wang
  • View Affiliations

  • Published online on: September 23, 2011     https://doi.org/10.3892/etm.2011.356
  • Pages: 105-108
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The objective of the present study was to evaluate the application potential of CyberKnife for high-risk tumors of the central nervous system and to analyze the effectiveness of CyberKnife in relation to dose recovery and gain division (times). A total of Eighty-one targeted areas from 139 central nervous tumor lesions in 60 patients were treated with I-VI ranged CyberKnife for 1 week. Following CyberKnife treatment, imaging tests revealed a decrease in tumor volume, reduction of central nervous system symptoms and an increase in the life quality of patients. The advantages of CyberKnife include non-invasiveness, individualized treatment, flexibility, high accuracy and rapid treatment. CyberKnife produces slight damage and a favorable therapeutic effect and expands our concepts concerning precise radiotherapy for tumors. It is an indispensable method for personalized tumor treatment.
View Figures
View References

Related Articles

Journal Cover

January 2012
Volume 3 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang X, Wang Y, Jiang P, Ma J, Qu Z, Liu H, Wang S and Wang Y: Clinical application of CyberKnife for high-risk central nervous system tumors: A clinical trial report of 60 cases. Exp Ther Med 3: 105-108, 2012
APA
Wang, X., Wang, Y., Jiang, P., Ma, J., Qu, Z., Liu, H. ... Wang, Y. (2012). Clinical application of CyberKnife for high-risk central nervous system tumors: A clinical trial report of 60 cases. Experimental and Therapeutic Medicine, 3, 105-108. https://doi.org/10.3892/etm.2011.356
MLA
Wang, X., Wang, Y., Jiang, P., Ma, J., Qu, Z., Liu, H., Wang, S., Wang, Y."Clinical application of CyberKnife for high-risk central nervous system tumors: A clinical trial report of 60 cases". Experimental and Therapeutic Medicine 3.1 (2012): 105-108.
Chicago
Wang, X., Wang, Y., Jiang, P., Ma, J., Qu, Z., Liu, H., Wang, S., Wang, Y."Clinical application of CyberKnife for high-risk central nervous system tumors: A clinical trial report of 60 cases". Experimental and Therapeutic Medicine 3, no. 1 (2012): 105-108. https://doi.org/10.3892/etm.2011.356